Malaysia’s Drug Control Authority (DCA), which was established under the Control of Drugs and Cosmetics Regulations 1984, is a government authority that ensures the safety, effectiveness and quality of cosmetic products marketed in Malaysia. The DCA is responsible for the registration and... Read More
The pharmaceutical industry in Malaysia is currently valued at more than US$300 million and is growing at an average annual rate of ten percent. By 2005, it is expected to account for 45.9 percent of the entire healthcare industry, or US$539.47 million... Read More
The US Trade Development Agency (TDA) estimates that developing countries in Asia will spend over $6 billion on healthcare technology over the next five years. There are at least 25 large-scale healthcare technology projects either underway or on the drawing board in... Read More
Despite sluggish economies in some countries, Asia still represents future growth opportunities in healthcare products. Over the next 20 years, Asian healthcare markets are expected to grow at a rate two and a half times that of the West. A rising standard... Read More
Though the government has indicated in the past that it plans to establish a medical device certification system, at present there are no requirements for registration of medical devices in Malaysia. Malaysia does require that FDA, CE mark, or other international approval... Read More
Recovering economies throughout Asia offer promising markets for foreign medical device firms as well as opportunities for local product development and manufacturing. Before the Asian financial crisis, regional medical device markets grew at double-digit rates. Patients wanted the technologically innovative, cost-effective devices... Read More
Thanks to significant government reform efforts since 1998, the Malaysian economy has been able to rebound from the Asian currency crisis of 1997. The costs of healthcare in Malaysia are on the rise and the government is looking to cut healthcare expenditure,... Read More
Despite its currency crisis, Asia still offers manufacturers many opportunities. Asia's recent currency crisis has caused some U.S. medical device companies to wonder whether there is still a market for their products and services. Concern has risen that Asians have lost their... Read More
Southeast Asia is becoming an increasingly important market for medical products, including products for diagnosing and treating infectious diseases. Pharmaceutical and diagnostics firms can take advantage of shorter regulatory procedures required in Brunei, Cambodia, Indonesia, Laos, Myanmar, the Philippines, Singapore, Thailand, and... Read More
This article contains analyses of healthcare trends and policies, and the role of foreign medical companies in China, Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Thailand and Vietnam. As Asia continues to be the fastest growing region in the world, economic... Read More